The global parenteral nutrition market size is projected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the presence of a large number of malnourished children, a high natality rate around the world, rising premature births, rising occurrence of cancer, which necessitates the administration of vital nutrients to increase hydration, energy, and strength of cancer patients, and rising adoption of nutrients in chronically ill geriatric patients by healthcare settings.
Parenteral nutrition (PN) is the intravenous administration of nutrition, such as protein, carbohydrate, fat, minerals and electrolytes, vitamins, and other trace elements, to patients who are unable to eat or absorb enough food through tube feeding formula or by mouth to maintain a healthy nutritional status. Getting the appropriate diet in a timely manner can help patients avoid problems and play a significant role in their recovery. Total Parenteral Nutrition is a term used to describe parenteral nutrition (TPN). Parenteral nourishment is given to people of all ages. It may be administered to newborns, children, and adults alike. Parenteral nourishment can keep people alive for as long as they need it. Parenteral nutrition is frequently administered for a brief period of time before being reduced or terminated when the person transitions to tube feeding or eats enough by mouth. Parenteral feeding skips the gastrointestinal (GI) tract's regular digesting process. An intravenous (IV) catheter is used to provide a sterile liquid chemical formula straight into the circulation (needle in the vein). Mouth sores, impaired night vision, and skin abnormalities are the most frequent adverse effects of parenteral feeding. Changes in heartbeat, confusion, convulsions or seizures, difficulty breathing, rapid weight gain or loss, fatigue, fever or chills, increased urination, jumpy reflexes, memory loss, muscle twitching, weakness, or cramps, stomach pain, swelling of your hands, feet, or legs, thirst, tingling in your hands or feet, vomiting, and tingling in your hands or feet are some of the less common side effects. After receiving parenteral nourishment, many patients see an improvement in their health. Individuals’ symptoms may not go away completely, but body may be able to recuperate more rapidly. Individual will probably feel stronger and more invigorated as a result. This might assist in doing more despite the consequences of illness. After a few weeks on this nutrition regimen, a physician or dietitian will review nutritional needs to see if any dose modifications are necessary. Individual almost certainly undergo exams to determine your specific requirements. Parenteral nutrition ensures that body's health and energy levels are maintained.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing incidence of malnutrition in both developing and developed nations is expected to fuel the market growth during the forecast period.
- Growing prevalence of metabolic disorders in conjunction with chronic diseases such as diabetes are projected to drive the market growth during the forecast period.
- Growing geriatric population and unhealthy lifestyle adoption are the key factors driving the market growth during the forecast period.
- Rapid industrialization, poor ingestion of a well-balanced nutritional diet, and the rising prevalence of chronic diseases are major factors propelling the market growth during the forecast period.
- Stringent regulation policies for approval of parenteral nutrition products in the emerging economies present as key challenge that can hamper the market growth during the forecast period.
- Lack of awareness possess as major factor that can impede the market growth during the forecast period.
- Extensive focus on R&D for novel product development and technological advancements are projected to offer lucrative opportunities for the market players in the coming future.
Scope of the Report
The report on the global parenteral nutrition market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | Parenteral Nutrition Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Nutrient Type (Carbohydrates, Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, and Vitamins & Minerals) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | Baxter International Inc.; Grifols International S.A.; Actavis Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; and Hospira Inc. |
Market Segment Insights
Single-dose amino acid solutions segment is expected to account for a key share
Based on nutrient type, the parenteral nutrition market is segmented into carbohydrates, lipid emulsion, single dose amino acid solution, trace elements, and vitamins & minerals. The single-dose amino acid solutions segment is expected to account for a key share of the market during the forecast period owing to increased use of amino acid solutions which is due to increase in the influx of regulatory approved solutions. Furthermore, newly accessible amino acid solutions have less adverse effects, boosting patient advantages.
On the other hand, the lipid emulsion segment is anticipated to expand at a rapid pace during the forecast period owing to its potential benefits as a drug delivery vehicle. It is mostly used to provide medications that prevent thrombophlebitis and relieve pain and discomfort. Pediatric patients are given lipid emulsions because they provide a non-carbohydrate source of energy with minimal osmolarity and volume. These lipid emulsions can also be used to keep parenteral feeding solutions in a net nitrogen balance. Furthermore, they are high in vital fatty acids.
North America is anticipated to dominate
On the basis of regions, the parenteral nutrition market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market CAGR during the forecast period. The regional market growth can be attributed to various significant research investment by government agencies and commercial organizations in the healthcare sector, technologically sophisticated medical devices, and cooperation among regulatory authorities, the medical device industry, and universities. Furthermore, the growing prevalence of various chronic diseases, the availability of sophisticated healthcare facilities, and advantageous reimbursement policies have resulted in an increase in hospital admissions, which is expected to raise the region's utilization rates.
On the other hand, Asia Pacific is expected to exhibit a rapid growth rate in the coming years due to economic development in countries such as China, India, and Japan, as well as favorable government efforts linked to the development of healthcare infrastructure and reimbursement policies. Furthermore, increasing Foreign Direct Investment (FDI) in the medical devices and healthcare sectors by different commercial and government entities is projected to provide incentives for the manufacture of technologically sophisticated goods throughout the projection period.
Segments
Segments Covered in the Report
The global parenteral nutrition market has been segmented on the basis of
Nutrient Types
- Carbohydrates
- Lipid Emulsion
- Single Dose Amino Acid Solution
- Trace Elements
- Vitamins & Minerals
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Baxter International Inc.
- Grifols International S.A.
- Actavis Inc.
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Hospira Inc.
Competitive Landscape
Key players competing in the parenteral nutrition market includes Baxter International Inc.; Grifols International S.A.; Actavis Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; and Hospira Inc.
Some of the key business strategies employed by companies includes mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
Request For Customization
Enquiry Before Buying
Speak With Analyst
